Loading…
Radiopaque poly(ε-caprolactone) as additive for X-ray imaging of temporary implantable medical devices
Implantable polymeric medical devices suffer from a lack of visibility under current clinical imaging techniques. To circumvent this problem, poly( epsilon -caprolactone-co- alpha -triiodobenz oate- epsilon -caprolactone)s (PCL-TIB) containing from 3.5% to 24% of triiodobenzoate- epsilon -caprolacto...
Saved in:
Published in: | RSC advances 2015-01, Vol.5 (102), p.84125-84133 |
---|---|
Main Authors: | , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | Implantable polymeric medical devices suffer from a lack of visibility under current clinical imaging techniques. To circumvent this problem, poly( epsilon -caprolactone-co- alpha -triiodobenz oate- epsilon -caprolactone)s (PCL-TIB) containing from 3.5% to 24% of triiodobenzoate- epsilon -caprolactone units were synthesized as new X-ray macromolecular contrast agents. Physico-chemical and thermal properties of PCL-TIBs were evaluated by super(1)H NMR, SEC, DSC and TGA. Their potential as radio-opacifying additive for medical devices was evaluated by preparing polymeric blends of PCL-TIB with various (co)polyesters. At first, in vitro X-ray visibility of PCL/PCL-TIB blends was evaluated. A more in depth characterization was then carried out based on PCL/PLA sub(50)-PEG-PLA sub(50) blends. The impact of PCL-TIB content on the mechanical properties of blends was evaluated by tensile tests. Stability of X-ray visibility was evaluated by ex vivo implantation of non-degraded blends and of blends degraded for 6 weeks in vitro. Finally, cytocompatibility was assessed by evaluating the proliferation of L929 fibroblasts on the blends. |
---|---|
ISSN: | 2046-2069 2046-2069 |
DOI: | 10.1039/c5ra19488a |